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Abstract 
The lateral mobility of the neural cell adhesion molecule (NCAM) was examined using fluorescence recovery after 
photobleaching (FRAP). Various isoforms of human NCAM, differing in their ectodomain, their membrane anchorage mode 
or in the size of their cytoplasmic domain, were expressed in NIH 3T3 cells and C2C12 muscle cells. When the various 
isoforms were compared in 3T3 cells, FRAP studies showed both GPI-anchored and transmembrane isoforms diffused 
rapidly and only small differences in either the diffusion coefficients (D) or the mobile fractions (mf) were measured, 
suggesting the importance of the ectodomain i  regulating lateral diffusion. However, the mobility of all NCAM isoforms 
was greatly reduced in regions of cell-cell contact, presumably due to homophilic trans interactions between NCAMs on 
adjacent cells. NCAM isoforms transfected into C2C12 cells which express NCAM naturally usually displayed a 
significantly lower D compared to the same isoforms transfected into 3T3 cells. Thus, NCAM lateral mobility is modulated 
in regions where cells interact and by the structure of the host cell membrane. © 1997 Elsevier Science B.V. 
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I. Introduction 
The nearly 30 members of the neural cell adhesion 
molecule (NCAM) family arise from a single gene 
that is alternatively spliced during transcription [1-7]. 
Different isoforms result in various forms of mem- 
brane anchorage, including membrane spanning pep- 
tides with different sized cytoplasmic domains or a 
glycosylphosphatidyl-inositol (GPI) linkage. Other 
isoforms have ectodomain variations that are cell 
type specific; these include a 37 amino acid insert, 
* Corresponding author. Fax: + 1-919-9661856. 
called the muscle specific domain (MSD) [7], and a 
10 amino acid insert derived from the VASE exon 
[4,8]. While NCAM has an important role in mediat- 
ing cell-cell adhesion, it is also involved in regulat- 
ing neurite outgrowth [1-5]. Compared to the 180 
kDa large cytoplasmic domain isoform, the GPI-lin- 
ked 120 and the 140 kDa isoform, containing a small 
cytoplasmic domain, are much more effective at pro- 
moting neurite outgrowth [5]. 
Considering the various functions of NCAM and 
the many isoforms, it was of interest to determine the 
lateral mobility of NCAM isoforms expressed by 
transfection i  various cell lines using FRAP. Mea- 
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surements were conducted in two cell types: 3T3 
cells in which NCAM is foreign and C2C12 muscle 
cells which naturally express NCAM. Since NCAM 
isoforms with the same or similar ectodomain have 
very different modes of membrane anchorage, these 
measurements allowed a further test of the hypothesis 
that, for at least certain membrane proteins, the mode 
of membrane anchorage does not affect lateral mobil- 
ity [9,10]. The FRAP data largely support this hy- 
pothesis and suggest hat for NCAM the ectodomain 
plays a more important role in regulating lateral 
mobility. However, the lateral mobility of these pro- 
teins depends on the cellular background: NCAM 
exhibits a larger diffusivity in 3T3 cells where it is 
foreign compared to C2C12 cells where it is ex- 
pressed naturally. 
Since 3T3 cells expressing NCAM serve as a 
substrate for neurite outgrowth, and NCAM on adja- 
cent cells must homophilically interact for such acti- 
vation to occur, it could be argued that NCAM lateral 
mobility is rate limiting for the initial interaction that 
triggers subsequent signal transduction. However, 
these experiments demonstrated that the potential of a 
given isoform expressed in the feeder cell layer to 
promote neurite outgrowth and its lateral mobility in 
these cells was not correlated. 
2. Materials and methods 
2.1. Cells and reagents 
C2C12 mouse muscle cells and NIH 3T3 fibrob- 
lasts were transfected with various isoforms of hu- 
man NCAM as described elsewhere [1,11]. Cells 
were routinely cultured in DMEM-H [Dulbecco's 
Modified Eagle Medium, with D-glucose, L-gluta- 
mine and sodium bicarbonate; H for high glucose (9 
g 1-t)], supplemented with 10% fetal bovine serum, 
and plated on 12 mm X 12 mm coverslips for the 
FRAP measurements two days prior to experiments. 
The anti-human NCAM (ERIC-l) is a mouse mAb 
IgG1 [12]; it was obtained from an ascites (Vector 
Labs, UK) and purified by ammonium sulfate precipi- 
tation followed by a protein G column using the mAb 
Trap Gl l  Kit (Pharmacia). Fab fragments were pro- 
duced by digestion with immobilized papain using a 
kit (Pierce Biochemicals, Rockford, IL) with the 
modification that a Protein G column was employed 
for removal of undigested IgG and Fc fragments. 
Fluorochrome conjugation to IgG and Fab fragments 
was carried out by dialyzing IgG/Fab (3 mg ml -~) 
into 100 mM Na carbonate/bicarbonate buffer at pH 
9.3. Rhodamine B isothiocyanate was added at a ratio 
of 10 mg/mg protein and stirred at 4°C for 16 h. A 
Sephadex G10 column was used to remove the ma- 
jority of free dye followed by extensive dialysis 
against PBS. The conjugated ERIC 1 was tested for 
activity by immunofluorescence titration against he 
human NCAM expressed in transfected 3T3 cells and 
compared to the original unconjugated IgG. No dif- 
ference in activity was observed indicating the reagent 
was not affected by the conjugation. 
2.2. FRAP studies 
Labelling for the FRAP measurements was accom- 
plished by washing the cells twice in HBSS(+) 
[Hank's balanced salts solution with calcium and 
magnesium] and then incubating the cells in the 
antibody solution (diluted with HBSS( + )) for 10 min 
at room temperature. Coverslips were mounted on a 
metal slide in HBSS(+) as previously described [13]. 
FRAP measurements were made on a Leitz Ortholux 
microscope mploying a Leitz 40 × oil objective lens 
(NA 1.3). The focused Gaussian laser beam radius 
was calculated to be about 1 mm. This calculation 
was confirmed by quantitative fluorescence mi- 
croscopy using digitized image processing. The 514 
nm line of a Spectra-Physics 164-07 argon 107 laser 
(Mountain View, CA) was used. Spots on the cell 
were bleached for 60-100 ms using a laser power of 
40-50 mW. After labelling the cells with 
rhodamine-conjugated anti-NCAM IgG or Fab frag- 
ments, FRAP measurements were performed at room 
temperature, periodically interrogating the fluores- 
cence recovery (pulse duration 0.5 s, time between 
pulses 2 s for 3T3 studies; pulse duration 1 s, time 
between pulses 2 s for C2C12 cells; the instrumenta- 
tion monitors recovery within each interrogation 
pulse). A 350 micron pinhole in the intermediate 
image plane was used to limit the collection depth of 
the photomultiplier. A single curve was recorded per 
transfected cell, and each coverslip was used for less 
than 1 h after antibody labelling. Fluorescence r cov- 
ery curves were analyzed using software developed 
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by Gordon et al. [14]. This approach requires the user 
to specify the prebleach fluorescence value, the final 
fluorescence value (after recovery is complete) and 
the baseline value for the recovery curve. 
We had previously discussed reasons for the up- 
ward drift of lateral diffusion coefficients reported by 
this laboratory [9]. We have now completed investi- 
gation of those factors. Control experiments indicate 
that the major source of the increase in D is due to a 
switch in technology in 1986 for attenuating the laser 
beam after photobleaching for the measurement phase 
of the FRAP experiment. The neutral density filters, 
polished to near parallelism, were exchanged for a 
beam splitter device which insures, when properly 
aligned, that the measuring beam is perfectly coinci- 
dent with the photobleaching laser beam [15]. The 
combination of factors previously enumerated, full 
curve fitting, and this prior improvement in beam 
attenuation produces an ca. 2-fold increase in the D 
values calculated from the FRAP curves when com- 
pared to the pre-1986 analysis. Since most of the 
biological conclusions are derived from comparisons 
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Fig. 1. The lateral mobility of NCAM isoforms expressed in 3T3 cells in regions of cell-cell contact as compared to other cell regions. 
Contact and non-contact regions were tested in separate experiments. Top panel, linear structures of the isoforms tested; middle panels, 
diffusion coefficients and mobile fractions; bottom panel, pre-bleach fluorescence intensity excited by the FRAP laser beam in 
non-contact vs. contact zones. Values (+ SEM). 
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of data taken under the same conditions, they are not 
affected by this upward revision of our D values. 
3. Results 
3.1. Lateral mobility of NCAM isoforms expressed in
3T3 cells 
Various human NCAM isoforms (Fig. 1) were 
expressed by gene transfer in 3T3 cells, which lack 
endogenous NCAM. These NCAM isoforms exhib- 
ited similar diffusion coefficients D and mobile frac- 
tions (Table 1). In particular, the mode of membrane 
anchorage [GPI-anchored (NCAM 120 and 125), or 
anchored by a small (NCAM 140) or large (NCAM 
180) cytoplasmic domain] or the presence of the 
VASE insert in the ectodomain did not affect lateral 
mobility significantly. All transfected isoforms tested 
also displayed a greatly reduced lateral diffusivity in 
contact regions of 3T3 cells, compared to other parts 
of the cells (Fig. 1, top data panel). The mobile 
fractions, however, remained unaffected by such con- 
tact (Fig. 1, middle data panel). For all isoforms 
except NCAM 120 the intensity in the contact zone 
was roughly doubled (Fig. 1, bottom data panel). We 
attribute this to the simple fact that two cell surfaces 
are measured in contact zones as a similar effect was 
measured for the glycoprotein, pgpl [CD44] [13]. 
However, we cannot rule out some increase in the 
surface density of NCAM in such regions. 
Control experiments indicated that the measured 
lateral mobility of all NCAM isoforms expressed in 
3T3 cells did not depend significantly on whether 
o~ 
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Fig. 2. Relative lateral mobility of various NCAM isoforms in 
3T3 cells using NCAM IgG or Fab fragments for the FRAP 
measurement. Top panel, relative diffusion coefficients expressed 
as the DFab/DIgG; bottom panel, relative mobile fractions ex- 
pressed as the ratio mobile fraction(Fab)/mobile fraction(IgG). 
intact IgG or Fab fragments were employed as labels 
for FRAP measurements (Fig. 2). 
3.2. Lateral mobility of NCAM isoforms expressed in
C2C12 muscle cells 
Human NCAM isoforms were also expressed, by 
gene transfer, in C2C12 muscle cells which possess 
an endogenous NCAM complement. These NCAM 
isoforms exhibited a 2- to 8- fold lower diffusivity in 
the C2C12 cells as compared to the 3T3 cells (Table 
Table 1 
Lateral mobility of human NCAM expressed by gene transfer in 3T3 and muscle cells a 
Isoform/cell type Human NCAM expressed in 3T3 cells 
D ( × 10 I° cm 2 s-  i) Mobile fraction (%) N 
Human NCAM expressed in C2C 12 cells 
D (× 1010 cm 2 s - t )  Mobile fraction (%) N 
120 24.3(+ 4.2) 57.5(_ 3.3) 19 
125 30.2( ± 6.6) 67.7( + 5.0) 18 
125 VASE - - - 
140 18.0(_+3.7) 60.9(___4.1) 21 
140 VASE 22.4( ± 3.6) 60.4( + 4.4) 23 
180 18.3( + 3.1) 61.4( ___ 4.7) 20 
10.9(+ 1.9) 44.3(_+4.0) 
3.7( ± 0.4) 69.1 ( ± 3.7) 
4.5(+ 0.8) 57.2(+ 3.5) 
4.7(± 0.5) 71.1(± 4.7) 
22 
20 
22 
23 
a Values (+ SEM). 
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Table 2 
Lateral mobility of endogenous NCAM in C2C12 muscle cells at 
various stages of differentiation 
Stage of D Mobile Number of 
differentiation (× |0 I° cm 2 s i) fraction (%) samples 
Myoblasts a 6.9( _+ 0.2) b 50.8( + 5.4) 26 
Midfusion 5.6(+ 0.2) 45.2(_+ 4.1) 32 
Myotubes c 5.3(_+ 0.2) 58.0(_+ 4.5) 28 
NCAM 140 predominantly expressed. 
i, Mean (_+ SEM). 
NCAM 125 (GPI-anchored) predominantly expressed. 
1). In the 3T3 cells, all transfected isoforms tested 
displayed iffusion coefficients between 18 × 10-1° 
and 30 × 10 -~° cm 2 s - s ,  whereas D ranged between 
4×10 -~° and 11×10 -~° cm 2 s -j in the muscle 
cells (Table 1). Mobile fractions were generally in the 
range of 50-70% (Table 1). The differences between 
the 120 and 125 kDa muscle isoforms for both D 
(p < 0.01) and mobile fraction (p < 0.01) are signif- 
icant but at this juncture we have no convincing 
explanation for them. 
The lateral mobility of endogenous NCAM was 
measured by FRAP in C2C12 cells in the myoblast, 
midfusion and the postfusion myotube state (Table 
2). The distribution of isoforms of the endogenous 
NCAMs expressed in the muscle cell changes during 
the transition from myoblasts to myotubes. The pre- 
dominant NCAM expressed in the myoblast stage is 
the transmembrane 140 kDa isoform whereas the 125 
kDa isoform is more prevalent in myotubes [16]. 
Lateral diffusion was slightly more rapid in the my- 
oblasts as compared to the myotubes with values for 
midfusion cultures falling in between (Table 2). The 
lateral diffusion coefficients were lower for the trans- 
fected isoforms as compared to the corresponding 
endogenous NCAM, but the mobile fractions were 
somewhat higher for the transfected isoforms (com- 
pare Tables 1 and 2). 
4. Discussion 
The present studies indicate that NCAM diffusivity 
on the micron distance scale as measured by FRAP 
is, in general, similar for different isoforms within the 
same cell background, but the diffusivity does depend 
on the cell type. Furthermore, where tested, the lat- 
eral transport properties measured by FRAP for en- 
dogenous isoforms were similar to those for NCAM 
isoforms expressed by gene transfer indicating the 
latter methodology was not introducing a significant 
artifact. 
Transfection of several NCAM isoforms into dif- 
ferent cell lines allowed comparison of NCAM mo- 
bility in cells where it is a completely foreign protein 
(3T3 cells) to cells that do express endogenous i o- 
forms of NCAM (C2C12). With the exception of 
NCAM 120 expressed in C2C12 cells, FRAP studies 
show that different NCAM isoforms, all having the 
same or similar ectodomains, have similar diffusivi- 
ties and mobile fractions in a given cell type, regard- 
less of the type of membrane anchorage or the size of 
the cytoplasmic domain. These results indicate the 
importance of the ectodomain as a determinant of 
NCAM lateral mobility, extending a conclusion 
reached by Zhang et al. [9] for various mutant mem- 
brane proteins derived from the VSV G glycoprotein. 
It may be postulated that the intrinsic lateral diffu- 
sivity of membrane proteins, determined by an effec- 
tive bilayer viscosity, is further educed by an effec- 
tive 'viscosity' of the pericellular matrix, through 
which the ectodomain must move [17,18], as well as 
by transient interactions with slowly diffusing or 
immobile structures [9,10]. The large and similar 
diffusion coefficients characterizing all NCAM iso- 
forms in 3T3 cells suggest hat the bilayer viscosity, 
acting on the membrane anchorage domains, and the 
pericellular matrix viscosity, acting on very similar 
ectodomains, determine NCAM diffusivity in these 
cells. 
Indeed, a number of diverse studies suggest hat 
ectodomain interactions, acting to produce viscous 
drag or indirectly by activating additional intramem- 
brane or cytoskeletal interactions, are a key determi- 
nant of lateral mobility. For example, reducing the 
effective size of the ectodomain, including molecules 
complexed to it, will act to increase the lateral mobil- 
ity. Genetic removal of the three oligosaccharides 
from a Class I MHC antigen increased its lateral 
diffusion coefficient 3 fold compared to the wild type 
antigen [19]. Zhang et al. [20] measured a 3 fold 
increase in the lateral diffusion coefficient of Thy-1, 
a GPI-anchored glycoprotein, comparing rhodamine 
IgG to rhodamine conjugated Thy-1 as labels for 
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FRAP studies. Modification of the extracellular ma- 
trix can reduce the effective viscous drag that this 
milieu exerts on the diffusing entity. In this regard, 
trypsin treatment of transformed and normal cells 
increased the lateral mobility of succinyl-Con A 
receptor(s) conjugates by 2- and 4-fold, respectively 
[21], suggesting that removal of extracellular matrix 
components can increase lateral mobility. 
The diffusivity of a number of transfected NCAM 
isoforms in contact regions of 3T3 cell cultures is 
much lower than in non-contact regions. This result 
can be interpreted in terms of the homophilic binding 
of NCAM expected to occur between cells which are 
in contact. This interpretation is supported by the fact 
that the cell surface glycoprotein pgp-1 [13] does not 
experience a reduction in its lateral mobility in re- 
gions of cell-cell contact. This molecule is not ex- 
pected to undergo homophilic trans interactions 
across cell-cell contacts. The reduction in mobility 
does not necessarily involve direct interaction of 
NCAM with the cytoskeleton as it occurs with GPI- 
anchored isoforms as well. 
It is conceivable that NCAM surface density is 
increased in the region of cell contact hereby reduc- 
ing its mobility and enhancing its potential for trans 
interactions between adjacent cells [22]. The fluores- 
cence intensity is approximately doubled in contact 
zones (Fig. 1) suggesting at most a two fold increase 
in NCAM surface density. However, a similar dou- 
bling of intensity is seen for overlapping regions of 
cells expressing the surface glycoprotein, pgpl, but 
no change in lateral mobility was measured in contact 
vs. non-contact zones [13]. We are thus inclined to 
interpret he increase in fluorescence to simple mor- 
phological effects, a doubling of the edges or surfaces 
interrogated by the FRAP measuring beam, as op- 
posed to pronounced accretion of NCAM in the 
contact zones. 
All transfected NCAM isoforms exhibit a signifi- 
cantly reduced lateral mobility in C2C12 cells as 
compared to 3T3 cells, whereas the mobile fractions 
remain basically unchanged. One possibility for this 
difference in diffusivity could be cis (or lateral) 
interactions of the diffusing NCAM with other mem- 
brane components, which may include endogenous 
NCAM or glycolipids in the C2C12 cells. Such puta- 
tive interactions could be caused, in part, by differen- 
tial glycosylation of NCAM in muscle cells and/or 
the presence of NCAM 'binding' proteins in the 
muscle cells. The latter includes cytoplasmic compo- 
nents binding to the cytoplasmic domain of NCAM 
which could reduce lateral mobility [23]. 
Pollerberg et al. [6] found that NCAM expressed 
endogenously in cultured mouse neuroblastoma cells 
also exhibited lower lateral diffusion coefficients [(1- 
2) × 10-10 cm 2 s- ~ at 4°C] than we found for human 
NCAM expressed in 3T3 cells. As the cells differen- 
tiate, the predominant NCAM isoform expressed 
changes from 140 to 180 kDa; concomitant with this 
change in expression, the mobile fraction drops 
markedly. In contrast, the differentiation of myoblasts 
to myotubes that occurs with a shift of expression 
from NCAM 140 to 125 as the predominant isoform 
[16] does not appreciably change the measured lateral 
mobility values (Table 2). 
Since NCAM-120 and NCAM-140 when ex- 
pressed in 3T3 cell monolayers demonstrate an abil- 
ity to enhance the outgrowth of neurites relative to 
the 140 VASE and the 180 isoforms of NCAM 
[1,4,5], but all isoforms have similar lateral mobility 
in 3T3 cells, it is clear that the long range (micron 
scale) lateral mobility of these NCAM isoforms is not 
correlated with the ability of a particular isoform to 
promote neurite outgrowth. 
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